Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Pain: Comorbidity of neuropathic pain and migraine in patients with multiple sclerosis.
Annotation of functional variation within non-MHC MS susceptibility loci through bioinformatics analysis.
Altered tract-specific white matter microstructure is related to poorer cognitive performance: The Rotterdam Study.
[Treatment of multiple sclerosis: new approaches to treat case by case].
Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord.
Exome and regulatory element sequencing of neuromyelitis optica patients.
[Animal model of neuromyelitis optica].
The diagnostic value of MRI in pediatric chronic inflammatory demyelinating polyradiculoneuropathy.
Advances in myelin imaging with potential clinical application to pediatric imaging.
Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients.
Multiple sclerosis and pregnancy: a comparison study.
Novel therapeutic options for multiple sclerosis.
Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists.
Cognitive impairment of Japanese multiple sclerosis patients: Follow-up study using BRB-N assessment tool.
Aquaporin-4: A novel diagnostic biomarker for seronegative neuromyelitis optica.
Dose-related effects of vitamin D on immune responses in patients with clinically isolated syndrome and healthy control participants: study protocol for an exploratory randomized double- blind placebo-controlled trial.
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
Burden and cost of neurological diseases: a European North-South comparison.
Correction: Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation.
Distress improves after mindfulness training for progressive MS: A pilot randomised trial.
Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives.
Psoriasis and comorbidities. Epidemiological studies.
Alterations in nerve-evoked bladder contractions in a coronavirus-induced mouse model of multiple sclerosis.
[Targeted Therapy and Progressive Multifocal Leukoencephalopathy (PML): PML in the Era of Monoclonal Antibody Therapies].

Pages